Endpoints News 3. März 2026 Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant
Cell 25. Feb. 2026 LUMI-lab: A foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery
Endpoints News 25. Feb. 2026 Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapy
Endpoints News 21. Feb. 2026 Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
Science 12. Feb. 2026 Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation | Science
FierceBiotech 12. Feb. 2026 UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
Endpoints News 11. Feb. 2026 Prasad overruled vaccine review team, office director on Moderna flu shot